RHYTHM PHARMACEUTICALS, INC. (RYTM) /

The debt of RHYTHM PHARMACEUTICALS, INC. over the past 10 years

Chart RHYTHM PHARMACEUTICALS, INC.: liquid cash, total debt, net cash, fiscal 2016–2025 Open the chart →

At the end of fiscal 2025, the latest fiscal year on file, RHYTHM PHARMACEUTICALS, INC. had liquid cash of $388.95M and total debt of $108.18M: net cash of $280.77M. It had more liquid cash than debt at all 10 year-ends shown. Total debt was highest at the end of fiscal 2024 ($109.81M) and lowest at the end of fiscal 2016 ($0).

Year by year

Fiscal yearLiquid cashTotal debt*Net cash*
2025ended Dec 31, 2025$388.95M*$108.18M$280.77M
2024ended Dec 31, 2024$320.56M*$109.81M$210.75M
2023ended Dec 31, 2023$275.85M*$106.14M$169.7M
2022ended Dec 31, 2022$333.29M*$0$333.29M
2021ended Dec 31, 2021$294.86M*$0$294.86M
2020ended Dec 31, 2020$172.79M*$0$172.79M
2019ended Dec 31, 2019$292.46M*$0$292.46M
2018ended Dec 31, 2018$252.06M*$0$252.06M
2017ended Dec 31, 2017$148.08M*$0$148.08M
2016ended Dec 31, 2016$10.54M*$0$10.54M

Fiscal years as RHYTHM PHARMACEUTICALS, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.

More on RHYTHM PHARMACEUTICALS, INC.

Companies of a similar size

Not investment advice. This page shows what RHYTHM PHARMACEUTICALS, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.